Pacific Biosciences Q4 Revenues Jump 43 Percent

Feb 06, 2020

|

NEW YORK – Pacific Biosciences reported after the close of the market Thursday that its fourth quarter 2019 revenues rose 43 percent.

The long-read sequencing technologies firm reported Q4 total revenues of $27.9 million, up from $19.5 million in Q4 of 2018 and beating analysts' average estimate of $25.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Featured White Papers

Genomic Solutions for Sensitive Viral Detection

Increased DNA Yield and Reduced PCR Duplicates Using the Ionic System

Isotachophoresis Improves Nucleic Acid Extraction and Purification from FFPE Samples

AI in Genomics: Progress through Innovation

Sep

30

Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

06

Featured Webinar

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease characterized by irreversible scarring of the distal lung, leading to respiratory failure.

Oct

08

Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct

13

Featured Webinar

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

This webinar will outline the use of targeted protein degradation (TPD) to understand transcriptional processes at a high kinetic resolution.

Menu

Pacific Biosciences Q4 Revenues Jump 43 Percent

To read the full story....

Breaking News

M2Gen Expands Partnership With Discovery Life Sciences

Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

In Brief This Week: Fluidigm, Thermo Fisher Scientific, Veracyte, and More

The Scan

This Time, Novavax

Shortened Visas for Some Students

New York's Own Review

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Understanding Human Pulmonary Fibrosis using Single-Cell Technologies

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Probing and Disrupting Oncogenic Gene Control via Targeted Protein Degradation

What's Popular?

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

Single-Cell Transcriptome Atlas of the Human Heart Highlights Heterogeneity

Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

Google DeepVariant Boosts Accuracy of Indel Calls in PacBio Long Reads

Sponsorships